Market Place
Sourcing Support
All News #Library
Biotech
Cadrenal`s Ph3 for CAD-1005 in Heparin-Induced Thrombocytopenia
30 Apr 2026 //
GLOBENEWSWIRE
Cadrenal Therapeutics Reports Q4 2025, CAD-1005 HIT Results
31 Mar 2026 //
GLOBENEWSWIRE
Cadrenal Therapeutics Showcases 12-LOX Inhibition Research
12 Mar 2026 //
GLOBENEWSWIRE
Cadrenal Therapeutics Expands 12-LOX Inhibitor Platform
02 Mar 2026 //
GLOBENEWSWIRE
Cadrenal Therapeutics Reports Positive Ph 2 Results for CAD-1005
24 Feb 2026 //
GLOBENEWSWIRE
Cadrenal Therapeutics Showcases VLX-1005 At J.P. Morgan Conf
12 Jan 2026 //
GLOBENEWSWIRE
Cadrenal`s Pipeline Shifts Towards Emergency Response System
30 Dec 2025 //
ACCESSWIRE
Cadrenal Revitalizes Overlooked Anticoagulation Areas
29 Dec 2025 //
PHARMIWEB
Cadrenal Therapeutics Acquires Phase 2 12-LOX Inhibitor VLX-1005
12 Dec 2025 //
GLOBENEWSWIRE
Cadrenal Therapeutics` CEO Quang X. Pham Wins BioFlorida Award
19 Nov 2025 //
GLOBENEWSWIRE
Cadrenal Therapeutics Reports Q3 Financials & Corporate Updates
10 Nov 2025 //
GLOBENEWSWIRE
Cadrenal Therapeutics Reports Full Year 2024 Results and Business
13 Mar 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.